Current Troubles at Johnson & Johnson

THE FOOD AND DRUG ADMINISTRATION investigation into quality-control problems at Johnson & Johnson's McNeil Consumer Healthcare division has shined a critical light on the OTC industry at a time when it can least afford such scrutiny. Although the public risk from these quality problems is low, these problems should never have occurred, stated Joshua Sharfstein, FDA deputy commissioner, in remarks

THE FOOD AND DRUG ADMINISTRATION investigation into quality-control problems at Johnson & Johnson's McNeil Consumer Healthcare division has shined a critical light on the OTC industry at a time when it can least afford such scrutiny.

“Although the public risk from these quality problems is low, these problems should never have occurred,” stated Joshua Sharfstein, FDA deputy comm

Register to view the full article

test - Advanced Registered User

Already a member? .